SCHEMBL19855059

SCHEMBL19855059

C=CC(=O)N(C)CCCCOc1ccc(-c2ccc(C3CCC(CCCCC)CC3)cc2)cc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRA P10827 2/20 0.41
▸ THRB P10828 2/20 0.41
▸ BTK Q06187 7/20 0.39
▸ TDP1 Q9NUW8 1/20 0.38
▸ ABCB11 O95342 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ ERBB2 P04626 1/20 0.36
▸ TEC P42680 1/20 0.36
▸ TXK P42681 1/20 0.36
▸ BLK P51451 1/20 0.36
▸ BMX P51813 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ ITK Q08881 1/20 0.36
▸ KCNH2 Q12809 1/20 0.36
▸ ERBB4 Q15303 1/20 0.36
▸ PI4KB Q9UBF8 1/20 0.36
▸ PTPN11 Q06124 2/20 0.35
▸ S1PR1 P21453 2/20 0.35
▸ FFAR4 Q5NUL3 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19854999 0.96 BTK (0.39) THRATHRBBTKTDP1ABCB11
SCHEMBL19854043 0.92 BTK (0.40) THRATHRBBTKTDP1ABCB11
SCHEMBL19855894 0.89 BTK (0.44) THRATHRBBTKTDP1ABCB11
SCHEMBL19855481 0.89 BTK (0.40) BTKABCB11EGFRERBB2TEC
SCHEMBL19854996 0.86 BTK (0.41) THRATHRBBTKABCB11EGFR
SCHEMBL19853897 0.86 BTK (0.43) THRATHRBBTKTDP1ABCB11
SCHEMBL19854992 0.85 BTK (0.35) BTKABCB11EGFRERBB2TEC
SCHEMBL19853813 0.85 DGAT1 (0.40) THRATHRBBTKEGFRITK
SCHEMBL20370508 0.84 CYP2C9 (0.43) BTKCYP2C9
SCHEMBL20370518 0.84 BTK (0.44) BTKABCB11EGFRERBB2TEC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 — — US disclosed
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 — — US disclosed
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-12 — — US disclosed
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-12 — — US disclosed
WO-2018025974-A1 LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE JNC株式会社 2018-02-08 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, MBD2, PAXBP1 THRA 3929/4885THRB 3939/4885BTK 4463/4885
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device SP1, MBD2, PAXBP1 THRA 3929/4885THRB 3939/4885BTK 4463/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback